Stay updated on Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3, reflecting the addition of v3.4.3 and removal of v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:29:01.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added a Revision: v3.4.2 tag. Removed the government funding lapse notice and the prior Revision: v3.4.1 tag.
    Difference
    0.4%
    Check dated 2026-02-11T02:57:45.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice regarding government funding status and NIH Clinical Center operations has been added, and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:47:49.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle and updated metadata labels, including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision version 'v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T00:20:17.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Only a revision tag was updated from v3.3.3 to v3.3.4; no study details or content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:48:24.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T09:50:56.000Z thumbnail image

Stay in the know with updates to Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembro & Tamoxifen in ESR1+ Breast Cancer Clinical Trial page.